Latest Regulatory Approval News

Emyria has secured a multi-year funding extension with Medibank to launch its Empax mental health programs in Brisbane, marking a key step in its national expansion. This insurer-backed initiative aims to improve access to treatment for complex conditions like treatment-resistant depression and PTSD.

Resolute Mining has agreed to support the sale of its 31.45 million shares in Loncor Gold to Chengtun Mining Group for C$1.38 per share, a move that will strengthen its balance sheet and accelerate key African projects.

Ainsworth Game Technology has lodged a supplementary statement supporting Novomatic’s unconditional takeover bid, even as its CEO resigns amid regulatory hurdles. The board unanimously recommends acceptance, with the offer deemed fair by an independent expert.

29Metals maintains steady copper output at Golden Grove despite seismic disruptions to zinc production, while progressing key growth projects and regulatory steps toward Capricorn Copper’s restart.

29Metals reports a steady copper output but significant zinc production decline due to seismic disruptions at Golden Grove, alongside rising operational costs and ongoing progress at Capricorn Copper.

Highfield Resources has locked in A$10 million through convertible notes from existing investors to tackle a key permit issue and push forward its flagship Muga Potash Project in Spain.

The Federal Court of Australia has approved the acquisition of NSX Limited by a related entity of the Canadian Securities Exchange operator, setting the stage for NSX’s delisting from the ASX later this month.

Clarity Pharmaceuticals’ Co-PSMA Phase II trial shows its Cu-SAR-bisPSMA diagnostic agent detects more prostate cancer lesions than current standard imaging, promising earlier and more accurate recurrence detection.

Resouro Strategic Metals is on track to close its non-brokered private placement within the week, aiming to fund critical engineering work for its Tiros Titanium-Rare Earths Project in Brazil.

Titanium Sands Limited has locked in $800,000 in stage two funding to complete environmental studies and advance the Industrial Mining Licence for its Mannar Island Project in Sri Lanka, backed by strong government support.

ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.

Yugo Metals has raised $3.5 million through a discounted placement to fund its first-ever diamond drilling program targeting gold anomalies at the Sinjakovo Project, with drilling set to commence in November 2025.